"Mediclinic Vergelegen is situated in the beautiful town of Somerset West in the Western Cape. It is a modern multidisciplinary hospital, well known for its high quality patient, medical and nursing care."

During the past decade, Vergelegen Medi-Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vergelegen Medi-Clinic" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Actelion" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Advanz Pharma" with 1 trials sponsored and "Astellas Pharma Inc" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vergelegen Medi-Clinic" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Vergelegen Medi-Clinic" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Pulmonary Arterial Hypertension" (2 trials), "Stroke" (2 trials), "Atrial Fibrillation" (1 trials) and "Brain Infarction" (1 trials). Many other conditions were trialed in "Vergelegen Medi-Clinic" in a lesser frequency.

Most popular intervention types in "Vergelegen Medi-Clinic" are "Drug" (12 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "placebo" (2 trials), "Acetaminophen/Paracetamol" (1 trials) and "Ancrod (Viprinex)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vergelegen Medi-Clinic" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Vergelegen Medi-Clinic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Vergelegen Medi-Clinic, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Vergelegen Medi-Clinic, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".